We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ONCOCYTE :Liquid Biopsy
An SI Board Since January 2016
Posts SubjectMarks Bans Symbol
29 4 0 OCX
Emcee:  Savant Type:  Moderated

About OncoCyte Corporation

OncoCyte is primarily focused on the development and commercialization of novel, non-invasive liquid biopsy diagnostic tests for the early detection of cancer to improve health outcomes through early diagnoses, to reduce the cost of care through the avoidance of more costly diagnostic procedures, including invasive biopsy and cystoscopic procedures, and to improve the quality of life for cancer patients.

While current biopsy tests use invasive surgical procedures to provide tissue samples in order to determine if a tumor is benign or malignant, OncoCyte is developing a next generation of diagnostic tests that will be liquid biopsies using blood or urine samples. OncoCyte’s initial liquid biopsy tests under development are intended to be confirmatory diagnostics for detecting lung, bladder and breast cancer. OncoCyte’s diagnostic tests are being developed using proprietary sets of genetic and protein markers broadly expressed in numerous types of cancer.

For more information about OncoCyte, please visit

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
29Bullish crossover in MACD and Stochastics. [graphic]hollyhunter-9/12/2017
28OCX..good news progress OncoCyte Receives CLIA Certification for its Cancer DiagSavant-9/7/2017
27FYI: Liquid biopsy startup RareCyte announces $30M round and new CEO to fuel raGlenn Petersen18/29/2017
26OncoCyte Confirms Launch Plans for Lung Cancer Diagnostic Test; Reports ProgressSavant-8/15/2017
25OncoCyte Latest Lung Cancer Diagnostic Test Data Accepted for Slide PresentationSavant-8/8/2017
24OncoCyte Corp. (OCX) filed a Form 8K - Unregistered Sales of Equity - with the USavant-7/31/2017
23OncoCyte Corporation Set to Join Russell 3000(R) Index ALAMEDA, Calif., June 12Savant-6/12/2017
22Presentation PDF >>> investors.oncocyte.comSavant-5/27/2017
21OncoCyte Presents Positive Lung Cancer Blood Test Data at American Thoracic SociSavant-5/23/2017
20lots of news, pps jump, stock halted, reopened..up 23.5%Savant-5/23/2017
19OncoCyte Reports Successful Results of Lung Cancer Diagnostic Test Study; TargetSavant-3/6/2017
18OncoCyte Corporation to Present at Cowen and Company 37th Annual Health Care ConSavant-3/1/2017
17Looks like good entry point here. [graphic]hollyhunter-2/27/2017
16OncoCyte Corporation Reports Fourth Quarter and Full Year 2016 Financial ResultsSavant-2/27/2017
15OncoCyte Wins Buzz of BIO for the 2017 BIO CEO & Investor Conference ALAMESavant-1/27/2017
14Bullish crossover in MACD and Stochastic oscillator. [graphic]hollyhunter-12/15/2016
13SAN DIEGO, Dec. 7, 2016 /PRNewswire/ -- Organovo Holdings, Inc. (NASDAQ:ONVO) (&Savant-12/7/2016
12DEC 9th presentation... OncoCyte Corporation (NYSE MKT:OCX), a developer of novSavant-11/30/2016
11OncoCyte and The Wistar Institute Present Lung Cancer Diagnostic Data at the CHESavant-10/17/2016
10OncoCyte Corporation to Present at the BIO Investor Forum ALAMEDA, Calif., Oct.Savant-10/14/2016
9OncoCyte to Present Initial Data on its Breast Cancer Diagnostic Test at the PreSavant-9/8/2016
8OncoCyte Corporation to Present at the Annual Gateway Conference ALAMEDA, CalifSavant-9/7/2016
7OncoCyte Corporation Announces the Closing of Two Private Placement TransactionsSavant-8/29/2016
6OncoCyte Commences Analytical Verification Study for Lung Cancer Diagnostic TestSavant-8/10/2016
5OncoCyte and The Wistar Institute Announce Presentation of Lung Data at CHEST 20Savant-7/27/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):